Salmon et al. showed that a therapy of Fit3L (growth factor for DCs) combined with poly1:C (a PAMP that activates DCs) can enhance the anti-tumour responses of CPIs in murine models by inducing CD103+ DC maturation, proliferation and activation. Here, ITGAE is linked to neoplasm.